Sur’s new next-generation testing

Sur patients now have access to exclusive discounted pricing on some of the most advanced early-detection tools available today.

Our new offerings:

• Prenuvo whole-body MRI

• Cleerly CCTA coronary plaque analysis

• Galleri multi-cancer screening test

• ApoE genetic testing for Alzheimer’s risk

These tests can reveal disease at its earliest and most actionable stages, far beyond what standard annual labs or imaging typically capture.

Our clinical team will help you decide which screenings are appropriate for your goals and risk profile, and guide you through the process from ordering to interpretation. If you’ve been considering any of these specialized evaluations, now is the ideal time to take advantage of preferred Sur pricing and personalized physician support.